Lonza recently announced a significant capacity expansion at its Stein, Switzerland, drug product facility. This Q&A paper provides more information about the added capabilities, how they complement its existing drug product network, and the benefits the expansion will bring for biopharmaceutical and biotech companies. 

See why leading pharma and biotech firms are rethinking staffing and turning insourcing into a long-term advantage. Download Now.

Discover how digital transformation can help cell and gene therapy manufacturers scale efficiently, reduce errors, and accelerate time to market—without compromising quality or compliance. Overcome scalability challenges and future-proof your production. Download this eGuide to learn more.